Explaining the increment in coronary heart disease mortality in Mexico between 2000 and 2012.

Carmen Arroyo-QuirozMartin O'FlahertyMaria Guzman-CastilloSimon CapewellEduardo Chuquiure-ValenzuelaCarlos Jerjes-SanchezTonatiuh Barrientos-Gutierrez

Published in: PloS one (2020)

CHD mortality in Mexico is increasing due to adverse trends in major risk factors and suboptimal use of CHD treatments. Population-level interventions to reduce CHD risk factors are urgently needed, along with increased access and equitable distribution of therapies.

Keyphrases

risk factors
cardiovascular events
physical activity
type diabetes
emergency department
adverse drug